Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-11

Clinical Trial Update: Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the safety and efficacy of a violet visible light blocking intraocular lens for cataract patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Violet Visible Light Blocking Intraocular Lens (intraocular lens)

Snippet

Sponsor: Abbott Medical Optics | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2011-11-11